Company

Erasca

Rocket Ship Rating

Rocket Ship Rating: 95 out of 100

Also known as Erasca, Inc

Biotech & therapeutics

Business model: B2B
Legal name: Erasca, Inc

erasca.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 29 September 2026

About

Clinical-stage precision oncology company targeting the RAS/MAPK pathway, affecting ~5.5 million lives annually worldwide.

Funding snapshot

Total raised: $184MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round: Round, $125M2020-04-15

Funding rounds

Round, 2020: $125M2020-04-15, SEC form D sold, 46 investors
Round, 2018: $58.3M2018-10-30, SEC form D sold, 41 investors